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ABSTRACT 
Objective: This study evaluated the seroprevalence of hepati- 
tis A virus (HAV) antibodies in 360 middle-class subjects from 
Buenos Aires City and its outskirts. 
Methods: The study population included 360 individuals 
between IO and 89 years of age, from the socioeconomic mid- 
dle class in Buenos Aires City and some suburban areas of 
Buenos Aires province. Antibodies to hepatitis A virus were 
determined by enzyme immunoassay test kits. 
Results: The overall prevalence of HAV antibodies was 42.2%. 
The highest percentage of seronegativity was found in the sub- 
group of younger people without a history of symptomatic 
hepatitis and living in houses with more than one bathroom 
(86.9%). In the subgroup aged 21 to 60 years, the highest 
rates of seronegativity were found in individuals with higher 
level of education living in houses with tap water (66.6%). In 
both groups, seronegativity may be correlated with a higher 
socioeconomic status. 
Conc/usions: In the middle-class community studied, more than 
50% of people under 30 years of age were unprotected against 
HAV Thus, the use of a vaccine against hepatitis A has to be 
considered for the prevention of symptomatic hepatitis, espe- 
cially in adults at risk of infection, such as those who travel to 
areas with poor sanitation, taking into consideration that the 
severity of the disease increases with age. 
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Hepatitis A virus (HAL’) infection is a worldwide disease 
that correlates with socioeconomic conditions. A relation 
between transmission rates with the level of hygiene and 
sanitation and with the age of the population has been 
described.l A sensitive and specific serologic test was 
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applied to large populations in different countries, to 
establish the epidemiology of this disease. Anti-HAV preva- 
lence at different ages shows patterns of high, interme- 
diate, or low endemicity, according to the geographic area 
examined.’ Argentina has been considered a high endemi- 
city area,3 but the sanitary and hygienic conditions vary. 
In some areas, most persons become infected in early 
childhood. In other areas, the sanitary conditions are gen- 
erally good, and most children younger than 10 years of 
age are anti-HAV negative.* In the Buenos Aires area (11 
million inhabitants), peak rates of infection are commonly 
expected to occur in adolescents and young adults. Out- 
breaks in child-care centers or residential institutions are 
expected. Also, travellers, homosexuals, or injection drug 
users have a higher chance of becoming infected. 
The authors assessed socioeconomic and living con- 
ditions in a sample of a middle-class population ranging 
from 10 to 89 years of age in Buenos Aires City and out- 
skirts, correlating these data with the measured anti-HAV 
prevalence, to evaluate the risk of developing the disease. 
MATERIALS AND METHODS 
A cross-sectional study was carried out in Buenos Aires 
City and in some suburban areas of Buenos Aires 
province. From December 1995 to June 1996 volunteers 
older than 10 years of age attending clinics for nonhep- 
atic diseases and interested in knowing their immunity 
against hepatitis A infection were enrolled. All of them 
belonged to the socioeconomic middle class, according 
to their income level. Individuals vaccinated against 
hepatitis A were excluded. All subjects or their parents 
gave full oral informed consent before sera collection. 
Name, age, sex, history of hepatitis, level of education, 
type of housing, number of people in household, number 
of bathrooms, and source of water supply were recorded. 
Serum samples from 360 individuals between 10 and 89 
years of age were taken and stored at -20°C until tested. 
Antibodies to HAV were detected using commercial 
enzyme immunoassay test kits (Hepanostika HAV anti- 
body Organon Teknika, The Netherlands). The clinical 
sensitivity of the test had a 100% correlation with the 
reference (WHO reference preparation) after repeat 
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Table 1. Percentage of Individuals within Each 
Age Group with Anti-HAV Serum Antibodies 
Age M 
Plumber of Patients 
(n = 360) 
Anti-HA!/+ 
(42.2%) 
RESULTS 
IO-12 57 
13-16 75 
17-20 75 
21-30 50 
31-60 53 
>61 50 
LR chi-square = 64.36; df = 5; P < 0.001. 
29.8 
26.6 
29.3 
44.0 
50.9 
88.0 
testing. The specificity after repeat testing was 100% 
(determined by Organon Teknika). This qualitative assay 
determined the presence of total antibodies (IgM and 
IgG) for HA&? 
Statistical Analysis 
Tree diagrams, cross-tabulations, and combination of cat- 
egories of predictor variables were performed using 
CHAID (&i-square automatic interaction detector) analy- 
sis software (SPSS@for WindowsTM, CHAIDTM, Release 6.0, 
SPSS Inc., Chicago, IL). Before and after merge subgroup 
minimum size was 5. Significance levels for merging and 
eligibility were 0.05. The P-value for cross-tabulations 
tables is the minimum of the likelihood-ratio (LR) chi- 
squared or the Bonferroni-adjusted statistic. The Bonfer- 
roni-adjusted P-value was used when categories were 
merged. 
pi 
Age Groups 
Hepatitis A virus antibodies were found in 152 (42.2%) 
of serum samples. The seroprevalence was similar in 
males (n = 164; 41.4%) and females (n = 196; 42.8%). 
The population studied was classified into six groups 
taking into consideration the number of subjects and 
their age. 
Table 1 shows that the number of seropositive indi- 
viduals increased with age. No significant differences 
were found in seroprevalence between the groups of 
individuals from 10 to 12,13 to 16, and 17 to 20 years of 
age, and the groups between 21 to 30 and 31 to 60 years 
of age. Thus, these groups were regrouped (lo-20 y and 
2 l-60 y). After this, the percentage of seronegativity was 
71.5% for the group of individuals aged 10 to 20 years and 
52.4% for the group 21 to 60 years. Thus, most people 
under 60 years of age were seronegative. The highest per- 
centage of seroprevalence was found in people older 
than 61 years. 
The analysis of all the predictor variables that may be 
related to seropositivity in the entire populations by the 
CHAID method showed the best model of significant pre- 
dictors (Figure 1). The best predictor of seropositivity 
was the age of the individuals. Within the subgroup of 
people 10 to 20 years of age the best predictor of 
seropositivity was previous symptomatic hepatitis. All the 
young who reported having had hepatitis were serum- 
positive, whereas only 24.9% of the young without this 
Symptomatic hepatitis School attendance (y) 
Bathrooms In) Tap water 
I I , 
Yes No Figure 1. Prevalence of anti-hepatitis A 
33.3 % 80.0 % serum antibodies. Significant predictor vari- ables. *Percentage of individuals with serum 
n = 66 n=5 antibodies to HAV; ttotal number of individ- 
uals of each subgroup. 
36 International Journal of Infectious Diseases / Volume 4, Number 1 
antecedent were seropositive (LR &i-square = 26.41; df 
= 1; P < 0.001). Within the subgroup of individuals from 
10 to 20 years of age without previous symptomatic 
hepatitis, the young living in a house with only one bath- 
room had a higher possibility of having antibodies to HAV 
(LR chi-square = 13.5; df = 1, P < 0.001). 
From a total population of 207 individuals, before 
the age of 20, only 59 (28.5%) were seropositive; 10 of 
59 (16.9%) had had symptomatic hepatitis, and 37 (75.5%) 
of the remaining 49 seropositive young people lived in 
houses with only one bathroom. 
In the subgroup of individuals from 21 to 60 years 
of age (n = lo?), the percentage of seropositives 
increased to 47.5%. The level of education achieved had 
an influence on the percentage of seropositivity. People 
with lower level of education had a higher incidence of 
seropositivity (LR &i-square = 17.5; df = 1; P < 0.001). 
Within the subgroup of individuals with a higher level of 
education, the higher percentage of seropositivity was 
present in the subgroup with no chlorinated tap water 
(LR chi-square = 4.26; df = 1; P < 0.05). In the subgroup 
of middle-aged people, the level of education was the 
main predictor of seropositivity. A higher percentage of 
seropositivity was present in individuals with a lower 
level of education. Only 3.3% of the population included 
in the study did not have tap water; however, the type of 
water intake appeared to significantly modify the per- 
centage of seropositivity in the subgroup with a higher 
level of education. The marital status and the number of 
family members in the same house had no significant 
relation with the dependent variable seropositivity when 
the population studied was divided into age groups. The 
gender had no significant relation with the dependent 
variable HAV seropositivity. It is interesting to note that 
not all the individuals who describe having had previous 
symptomatic hepatitis (n = 24) were found to have anti- 
bodies to HAV (19 positive; 5 negative). 
The higher percentages of seropositivity were 
reached by individuals belonging to the subgroups of 
younger people with a history of symptomatic hepatitis, 
middle-aged individuals with lower level of education, 
and individuals older than 61 years (see Figure 1). The 
highest percentage of seronegativity was found in the 
subgroup of younger people without a history of symp- 
tomatic hepatitis and living in houses with more than 
one bathroom. Intermediate values of seronegativity 
(between 50% and 70%) were found in middle-aged indi- 
viduals. Within this group, the highest rates of seronega- 
tivity were found in individuals with a higher level of 
education. The seronegative rate was higher in the sub- 
group with tap water. 
DISCUSSION 
Hepatitis A virus infection used to be a benign child- 
hood illness. Now, as both sanitary and socioeconomic 
conditions have improved in some areas of the world, the 
age of infection has shifted to older groups, and as a con- 
sequence, the number of symptomatic cases has 
increased. The seriousness of the disease is related to 
the age of the subject involved.5x6 
Although the disease incidence and prevalence have 
decreased in recent years, a resurgence of HAV infection, 
partly related to injection drug use, has been found in 
some developed countries3 
In the area studied, the rate of reported IL&V disease 
increased during the period 1993 to I996 from 30.9 per 
10,000 to 89.9 per 10,000 in Buenos Aires Province and 
from 17.4 per 10,000 to 65.3 per 10,000 in Buenos Aires 
City.’ In a middle-class population it was found that the 
younger subjects had HAV seroprevalence similar to that 
of the children younger than 10 years described by Gon- 
zalez et al in a previous study in the same geographic 
area (Buenos Aires City, 29.4%).* The majority of cases 
studied live in houses with tap water. However, some 
people lived in suburban areas where the water supply 
came from a well. The possibility of water contamination 
with sewage potentially containing HAV cannot be 
excluded. As expected, it was found that seroprevalence 
increased with age. This could be explained either by 
the years of exposure to the virus or the improved san- 
itary conditions that now exist compared to those in 
previous decades. The high percentage of seroprevalence 
in people older than 60 years may reflect the lower 
standards of hygiene common in the first half of the 
century. 
The pattern found indicates that in each studied 
period, the anti-IIAV prevalence was higher than the val- 
ues found in countries with very low or low incidences, 
such as Sweden and the United States, and lower than 
the values found in countries with intermediate values, 
such as Greece.3 
Compared to Spain, seroprevalence rates were higher 
in individuals under 20 years and lower in the groups 
between 21 and 60 years of age.8 The mean seropositiv- 
ity of all the population studied was 42.2%, and in the old- 
est group it reached 88%. This value represents a low to 
intermediate pattern of seroprevalence. However, 
Argentina has been considered a country with high preva- 
lence of HAV infection.3s4 The antibody level among blood 
donors showed over 80% positivity for anti-HAV IgG.* In 
a study in children younger than 10 years, it was found 
that the prevalence can vary from 81.4% to 29.4%, 
depending on the region sampled. The high degree of 
variation was attributable to different sanitary conditions.* 
The different results found in the present sample may 
reflect the fact that an urban middle-class population was 
analyzed. 
When the factors (predictor variables studied) asso- 
ciated with seropositivity were considered, it was found 
that subjects under 20 years of age without previous 
symptomatic hepatitis and living in houses with more 
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than one bathroom (conditions that may imply better 
socioeconomic status) have a lower incidence of sero- 
prevalence. 
People between 21 and 60 years of age have a rate 
of seropositivity that is associated with the level of edu- 
cation achieved. A lower level of school attendance 
implies a higher level of seropositivity. This may suggest 
that people with a better level of education have better 
health habits. Also, high level of education is assumed to 
be associated with high personal income, a factor that in 
the United States was inversely associated with anti-HAV 
prevalence.9 However, the sanitary facilities of the place 
where the subjects live may have conditioned the degree 
of infection, because a difference was found among peo- 
ple with higher education living in houses with or with- 
out tap water. 
The positive association described between anti- 
HAV antibody status and the number of family mem- 
bers within the household was not found in this study 
when the variable age was considered.‘O This factor 
carried less weight than other factors, such as level of 
education, previous clinical hepatitis, or the source of 
drinking water. 
CONCLUSIONS 
In the United States, a country with a low prevalence 
of anti-HAV,, case-fatality rates reported for children 
under 5 years of age were 1.5 per 1000, and among per- 
sons 50 years of age or older, 27 per 1000.ll In the mid- 
dle-class community studied, more than 50% of people 
under 30 years of age did not have antibodies to HAL? 
Thus, the use of a vaccine against hepatitis A has to be 
considered for the prevention of the symptomatic 
hepatitis, taking into consideration that the severity of 
the disease increases with age. Also, the economic inci- 
dence of the disease has to be considered. In Hong 
Kong, a cost:benefit ratio for vaccination of 9.48 was 
calculated when the cost of treatment and the loss of 
productivity were considered.12 
This study suggests that immunization programs tar- 
geted to populations at risk, such as frequent travellers 
to high-incidence areas and individuals between 20 and 
40 years of age, can be advantageous. 
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